Economic evaluation of an HIV prevention intervention for gay and bisexual male adolescents

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 1, 1998, Pages 83-90

  Tao, Guoyu ^a   Remafedi, Gary ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cost effectiveness; Gay and bisexual adolescents; HIV transmission model; Intervention; Quality adjusted life years

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BISEXUALITY; COST EFFECTIVENESS ANALYSIS; COUNSELING; ECONOMIC EVALUATION; GROUP PSYCHOLOGY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SOCIETY; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031963210     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199801010-00013     Document Type: Article

References (46)

1. Remafedi G. Cognitive and behavioral adaptations to HIV/AIDS among gay and bisexual adolescents. J Adolesc Health 1994;15: 142-8.
2. Russell LB, Siegel JE, Daniels N, Gold MR, Luce BR, Mandelblatt JS. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:3-24.
3. Holtgrave DR, Qualls NL, Graham JD. Economic evaluation of HIV prevention programs. Annu Rev Public Health 1996;17:467-88.
4. Holtgrave DR, Quails NL. Threshold analysis and programs for prevention of HIV infection. Med Decis Making 1995;15:311-17.
5. National Community AIDS Partnership. Evaluating HIV/AIDS prevention programs in community-based organizations. Washington, D. C.:National Community AIDS Partnership, 1993:9-14.
6. The Panel on Cost-Effectiveness in Health and Medicine. Summary Recommendations. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996:304-11.
7. Rowley JT, Anderson RM. Modeling the impact and cost-effectiveness of HIV prevention efforts. AIDS 1994;8:539-48.
8. Hoover DR, Carey MA, Chmiel V, et al. Estimating the 1978-1990 and future spread of human immunodeficiency virus type 1 in subgroups of homosexual men. Am J Epidemiol 1991;134:1190-1205.
9. Kaplan EH, Abramson PR. So what if the program ain't perfect? A mathematical model of AIDS education. Evaluation Rev 1989;13: 107-122.
10. Grant RM, Wiley JA, Winkelstein W. Infectivity of the human immunodeficiency virus: estimates from a perspective study of homosexual men. J Infect Dis 1987;156:189-93.
11. Kaplan EH. Modeling HIV infectivity: must sex be counted? J Acquir Immune Defic Syndr 1990;3:55-61.
12. Bremermann HJ, Anderson RW. Mathematical model of HIV infection. I. Threshold conditions for transmission and host survival. J Acquir Immune Defic Syndr 1990;3:1129-34.
13. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991;253:37-42.
14. Anderson RM. The role of mathematical model in the study of HIV transmission and the epidemiology of AIDS. J Acquir Immune Defic Syndr 1988;1:241-56.
15. Winkelstein W, Lyman DM, Padian N, et al. Sexual practices and risk of infection by the human immunodeficiency virus. JAMA 1987;257:321-5.
16. Kingsley LA, Detels R, Kaslow R, et al. Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Lancet 1987;1:345-9.
17. Giesecke J, Ramstedt K, Granath F, Ripa T, Rado G, Westrell M. Partner notification as a tool for research in HIV epidemiology: behavior change, transmission risk and incidence trends. AIDS 1992;6:101-7.
18. Detels R, English P, Visscher BR, et al. Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr 1989;2:77-83.
19. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Atlanta: U.S. Department of Health and Human Services, 1994;6:34.
20. Sweeney P, Lindegren ML, Buehler JW, Onorato IM, Janssen RS. Teenagers at risk of human immunodeficiency virus type 1 infection: results from seroprevalence surveys in the United States. Arch Pediatr Adolesc Med 1995;149:521-8.
21. Lemp GF, Hirozawa AM, Givertz D, et al. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men: the San Francisco/Berkeley Young Men's Survey. JAMA 1994; 272:449-54.
22. Brookmeyer R, Gail MH. AIDS epidemiology: a quantitative approach. New York: Oxford University Press, 1994:231-60.
23. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
24. Remafedi G, Resnick MR, Blum RW, Harris L. The demography of sexual orientation in adolescents. Pediatrics 1992;89:714-21.
25. Povinelli M, Remafedi G, Tao G. Trends and predictors of human immunodeficiency virus antibody testing by homosexual and bisexual adolescent males, 1989-1994. Arch Pediatr Adolesc Med 1996;150:33-8.
26. Jacquez JA, Koopman JS, Simon CP, Longini IM. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:1169-84.
27. Ahlgren DJ, Gorny MK, Stein AC. Model-based optimization of infectivity parameters: a study of the early epidemic in San Francisco. J Acquir Immune Defic Syndr Hum Retrovirol 1990;3:631-43.
28. DeGruttola V, Seage GR, Mayer KH, Horsburgh CR. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 1989;42:849-856.
29. Lazzarin A, Saracco A, Musicco A, et al. Man-to-women sexual transmission of the human immunodeficiency virus: risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Arch Intern Med 1991;151:2411-16.
30. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991;266:1164-7.
31. De Vincenzi I. Heterosexual transmission of HIV [letter]. JAMA 1992;267:1919.
32. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA 1993;270:474-8.
33. Guinam ME, Farnham PG, Holtgrave DR. Estimating the value of preventing a human immunodeficiency virus infection. Am J Prev Med 1994;10:1-4.
34. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. Consumer price index: prevention effectiveness. New York: Oxford University Press, 1996:186.
35. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. Productivity loss tables: prevention effectiveness. New York: Oxford University Press, 1996:187-92.
36. Farnham PG, Gorsky RD. Costs to business for an HIV-infected worker. Inquiry 1994;31:76-88.
37. Owens DK, Nease RF, Harris R. Use of cost-effectiveness and value of information analyses to customize guidelines for specific clinical practice settings [abstract]. Med Decis Making 1993;13: 395.
38. Laupacis A, Feeny D, Detsky AS, Tugwell PX. Tentative guidelines for using clinical and economic evaluations revisited. Can Med Assoc J 1993;148:927-9.
39. Holtgrave DR, Kelly JA. Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. Am J Public Health 1996;86:1442-5.
40. Pinkerton SD, Holtgrave DR, Valdiserri RO. Cost-effectiveness of HIV-prevention skills training for men who have sex with men. AIDS 1997;11:347-57
41. Kenrick DT, Keefe RC, Bryan A, et. al. Age preferences and mate choice among homosexuals and heterosexuals: a case for modular psychological mechanisms. J Personality Social Psychol 1995;69: 1166-72.
42. McKusick L, Coates TJ, Morin SF, Pollack L, Hoff C. Longitudinal predictors of reductions in unprotected anal intercourse among gay men in San Francisco: the AIDS behavioral research project. Am J Public Health 1990;80:978-83.
43. Ekstrand ML, Coates TJ, Maintenance of safer sexual behaviors and predictors of risky sex: the San Francisco Men's health study. Am J Public Health 1990;80:973-7.
44. Gorsky RD, MacGowan RJ, Swanson NM, DelGado BP. Prevention of HIV infection in drug abusers: a cost analysis. Prev Med 1995;24:3-8.
45. Owens DK, Nease RF, Harris RA. Cost-effectiveness of HIV screening in acute care settings. Arch Intern Med 1996;156:394-404.
46. Koopman JS. Comment: emerging objectives and methods in epidemiology. Am J Public Health 1996;86:630-2.